 | • レポートコード：GIR-107A14738 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、鎌状赤血球症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。鎌状赤血球症治療薬の種類別市場規模（ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・鎌状赤血球症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Acceleron Pharma Inc、Addmedica SAS、Angiocrine Bioscience Inc、Annexin Pharmaceuticals AB、ArQule Inc、Bio Products Laboratory Ltd、Bioverativ Inc、bluebird bio Inc、Bristol-Myers Squibb Co、Calimmune Inc、CRISPR Therapeutics、CSL Ltd、Daiichi Sankyo Co Ltd、Editas Medicine Inc、Errant Gene Therapeutics LLC、Gamida Cell Ltd、Genethon SA、Gilead Sciences Inc、Global Blood Therapeutics Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・鎌状赤血球症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・鎌状赤血球症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・鎌状赤血球症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・鎌状赤血球症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・鎌状赤血球症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Sickle Cell Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Sickle Cell Disease Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Sickle Cell Disease Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Sickle Cell Disease Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Sickle Cell Disease Drug market are listed below:
Acceleron Pharma Inc
Addmedica SAS
Angiocrine Bioscience Inc
Annexin Pharmaceuticals AB
ArQule Inc
Bio Products Laboratory Ltd
Bioverativ Inc
bluebird bio Inc
Bristol-Myers Squibb Co
Calimmune Inc
CRISPR Therapeutics
CSL Ltd
Daiichi Sankyo Co Ltd
Editas Medicine Inc
Errant Gene Therapeutics LLC
Gamida Cell Ltd
Genethon SA
Gilead Sciences Inc
Global Blood Therapeutics Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Sickle Cell Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sickle Cell Disease Drug, with price, sales, revenue and global market share of Sickle Cell Disease Drug from 2019 to 2021.
Chapter 3, the Sickle Cell Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sickle Cell Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Sickle Cell Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Sickle Cell Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Sickle Cell Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sickle Cell Disease Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 ARQ-092
1.2.3 BIVV-003
1.2.4 CAL-H
1.2.5 CTX-001
1.2.6 DRX-194
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Sickle Cell Disease Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Sickle Cell Disease Drug Market Size & Forecast
1.4.1 Global Sickle Cell Disease Drug Sales in Value (2016-2026))
1.4.2 Global Sickle Cell Disease Drug Sales in Volume (2016-2026)
1.4.3 Global Sickle Cell Disease Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Sickle Cell Disease Drug Production Capacity Analysis
1.5.1 Global Sickle Cell Disease Drug Total Production Capacity (2016-2026)
1.5.2 Global Sickle Cell Disease Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sickle Cell Disease Drug Market Drivers
1.6.2 Sickle Cell Disease Drug Market Restraints
1.6.3 Sickle Cell Disease Drug Trends Analysis
2 Manufacturers Profiles
2.1 Acceleron Pharma Inc
2.1.1 Acceleron Pharma Inc Details
2.1.2 Acceleron Pharma Inc Major Business
2.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Product and Services
2.1.4 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Addmedica SAS
2.2.1 Addmedica SAS Details
2.2.2 Addmedica SAS Major Business
2.2.3 Addmedica SAS Sickle Cell Disease Drug Product and Services
2.2.4 Addmedica SAS Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Angiocrine Bioscience Inc
2.3.1 Angiocrine Bioscience Inc Details
2.3.2 Angiocrine Bioscience Inc Major Business
2.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Product and Services
2.3.4 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Annexin Pharmaceuticals AB
2.4.1 Annexin Pharmaceuticals AB Details
2.4.2 Annexin Pharmaceuticals AB Major Business
2.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product and Services
2.4.4 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 ArQule Inc
2.5.1 ArQule Inc Details
2.5.2 ArQule Inc Major Business
2.5.3 ArQule Inc Sickle Cell Disease Drug Product and Services
2.5.4 ArQule Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Bio Products Laboratory Ltd
2.6.1 Bio Products Laboratory Ltd Details
2.6.2 Bio Products Laboratory Ltd Major Business
2.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Product and Services
2.6.4 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Bioverativ Inc
2.7.1 Bioverativ Inc Details
2.7.2 Bioverativ Inc Major Business
2.7.3 Bioverativ Inc Sickle Cell Disease Drug Product and Services
2.7.4 Bioverativ Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 bluebird bio Inc
2.8.1 bluebird bio Inc Details
2.8.2 bluebird bio Inc Major Business
2.8.3 bluebird bio Inc Sickle Cell Disease Drug Product and Services
2.8.4 bluebird bio Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Bristol-Myers Squibb Co
2.9.1 Bristol-Myers Squibb Co Details
2.9.2 Bristol-Myers Squibb Co Major Business
2.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Product and Services
2.9.4 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Calimmune Inc
2.10.1 Calimmune Inc Details
2.10.2 Calimmune Inc Major Business
2.10.3 Calimmune Inc Sickle Cell Disease Drug Product and Services
2.10.4 Calimmune Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 CRISPR Therapeutics
2.11.1 CRISPR Therapeutics Details
2.11.2 CRISPR Therapeutics Major Business
2.11.3 CRISPR Therapeutics Sickle Cell Disease Drug Product and Services
2.11.4 CRISPR Therapeutics Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 CSL Ltd
2.12.1 CSL Ltd Details
2.12.2 CSL Ltd Major Business
2.12.3 CSL Ltd Sickle Cell Disease Drug Product and Services
2.12.4 CSL Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Daiichi Sankyo Co Ltd
2.13.1 Daiichi Sankyo Co Ltd Details
2.13.2 Daiichi Sankyo Co Ltd Major Business
2.13.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product and Services
2.13.4 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Editas Medicine Inc
2.14.1 Editas Medicine Inc Details
2.14.2 Editas Medicine Inc Major Business
2.14.3 Editas Medicine Inc Sickle Cell Disease Drug Product and Services
2.14.4 Editas Medicine Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Errant Gene Therapeutics LLC
2.15.1 Errant Gene Therapeutics LLC Details
2.15.2 Errant Gene Therapeutics LLC Major Business
2.15.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product and Services
2.15.4 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Gamida Cell Ltd
2.16.1 Gamida Cell Ltd Details
2.16.2 Gamida Cell Ltd Major Business
2.16.3 Gamida Cell Ltd Sickle Cell Disease Drug Product and Services
2.16.4 Gamida Cell Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Genethon SA
2.17.1 Genethon SA Details
2.17.2 Genethon SA Major Business
2.17.3 Genethon SA Sickle Cell Disease Drug Product and Services
2.17.4 Genethon SA Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Gilead Sciences Inc
2.18.1 Gilead Sciences Inc Details
2.18.2 Gilead Sciences Inc Major Business
2.18.3 Gilead Sciences Inc Sickle Cell Disease Drug Product and Services
2.18.4 Gilead Sciences Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Global Blood Therapeutics Inc
2.19.1 Global Blood Therapeutics Inc Details
2.19.2 Global Blood Therapeutics Inc Major Business
2.19.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Product and Services
2.19.4 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Sickle Cell Disease Drug Sales by Manufacturer
3.1 Global Sickle Cell Disease Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Sickle Cell Disease Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Sickle Cell Disease Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Sickle Cell Disease Drug Manufacturer Market Share
3.4.2 Top 6 Sickle Cell Disease Drug Manufacturer Market Share
3.5 Global Sickle Cell Disease Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Sickle Cell Disease Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sickle Cell Disease Drug Market Size by Region
4.1.1 Global Sickle Cell Disease Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Sickle Cell Disease Drug Revenue by Region (2016-2026)
4.2 North America Sickle Cell Disease Drug Revenue (2016-2026)
4.3 Europe Sickle Cell Disease Drug Revenue (2016-2026)
4.4 Asia-Pacific Sickle Cell Disease Drug Revenue (2016-2026)
4.5 South America Sickle Cell Disease Drug Revenue (2016-2026)
4.6 Middle East and Africa Sickle Cell Disease Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Sickle Cell Disease Drug Sales in Volume by Type (2016-2026)
5.2 Global Sickle Cell Disease Drug Revenue by Type (2016-2026)
5.3 Global Sickle Cell Disease Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Sickle Cell Disease Drug Sales in Volume by Application (2016-2026)
6.2 Global Sickle Cell Disease Drug Revenue by Application (2016-2026)
6.3 Global Sickle Cell Disease Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Sickle Cell Disease Drug Sales by Type (2016-2026)
7.2 North America Sickle Cell Disease Drug Sales by Application (2016-2026)
7.3 North America Sickle Cell Disease Drug Market Size by Country
7.3.1 North America Sickle Cell Disease Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Sickle Cell Disease Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Sickle Cell Disease Drug Sales by Type (2016-2026)
8.2 Europe Sickle Cell Disease Drug Sales by Application (2016-2026)
8.3 Europe Sickle Cell Disease Drug Market Size by Country
8.3.1 Europe Sickle Cell Disease Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Sickle Cell Disease Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Sickle Cell Disease Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Sickle Cell Disease Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Sickle Cell Disease Drug Market Size by Region
9.3.1 Asia-Pacific Sickle Cell Disease Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Sickle Cell Disease Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Sickle Cell Disease Drug Sales by Type (2016-2026)
10.2 South America Sickle Cell Disease Drug Sales by Application (2016-2026)
10.3 South America Sickle Cell Disease Drug Market Size by Country
10.3.1 South America Sickle Cell Disease Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Sickle Cell Disease Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sickle Cell Disease Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Sickle Cell Disease Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Sickle Cell Disease Drug Market Size by Country
11.3.1 Middle East & Africa Sickle Cell Disease Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Sickle Cell Disease Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Sickle Cell Disease Drug Typical Distributors
12.3 Sickle Cell Disease Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Sickle Cell Disease Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Sickle Cell Disease Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Acceleron Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 4. Acceleron Pharma Inc Major Business
Table 5. Acceleron Pharma Inc Sickle Cell Disease Drug Product and Services
Table 6. Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Addmedica SAS Basic Information, Manufacturing Base and Competitors
Table 8. Addmedica SAS Major Business
Table 9. Addmedica SAS Sickle Cell Disease Drug Product and Services
Table 10. Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Angiocrine Bioscience Inc Basic Information, Manufacturing Base and Competitors
Table 12. Angiocrine Bioscience Inc Major Business
Table 13. Angiocrine Bioscience Inc Sickle Cell Disease Drug Product and Services
Table 14. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Annexin Pharmaceuticals AB Basic Information, Manufacturing Base and Competitors
Table 16. Annexin Pharmaceuticals AB Major Business
Table 17. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product and Services
Table 18. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. ArQule Inc Basic Information, Manufacturing Base and Competitors
Table 20. ArQule Inc Major Business
Table 21. ArQule Inc Sickle Cell Disease Drug Product and Services
Table 22. ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bio Products Laboratory Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Bio Products Laboratory Ltd Major Business
Table 25. Bio Products Laboratory Ltd Sickle Cell Disease Drug Product and Services
Table 26. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bioverativ Inc Basic Information, Manufacturing Base and Competitors
Table 28. Bioverativ Inc Major Business
Table 29. Bioverativ Inc Sickle Cell Disease Drug Product and Services
Table 30. Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. bluebird bio Inc Basic Information, Manufacturing Base and Competitors
Table 32. bluebird bio Inc Major Business
Table 33. bluebird bio Inc Sickle Cell Disease Drug Product and Services
Table 34. bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table 36. Bristol-Myers Squibb Co Major Business
Table 37. Bristol-Myers Squibb Co Sickle Cell Disease Drug Product and Services
Table 38. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Calimmune Inc Basic Information, Manufacturing Base and Competitors
Table 40. Calimmune Inc Major Business
Table 41. Calimmune Inc Sickle Cell Disease Drug Product and Services
Table 42. Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 44. CRISPR Therapeutics Major Business
Table 45. CRISPR Therapeutics Sickle Cell Disease Drug Product and Services
Table 46. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. CSL Ltd Basic Information, Manufacturing Base and Competitors
Table 48. CSL Ltd Major Business
Table 49. CSL Ltd Sickle Cell Disease Drug Product and Services
Table 50. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table 52. Daiichi Sankyo Co Ltd Major Business
Table 53. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product and Services
Table 54. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Editas Medicine Inc Basic Information, Manufacturing Base and Competitors
Table 56. Editas Medicine Inc Major Business
Table 57. Editas Medicine Inc Sickle Cell Disease Drug Product and Services
Table 58. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Errant Gene Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table 60. Errant Gene Therapeutics LLC Major Business
Table 61. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product and Services
Table 62. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Gamida Cell Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Gamida Cell Ltd Major Business
Table 65. Gamida Cell Ltd Sickle Cell Disease Drug Product and Services
Table 66. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Genethon SA Basic Information, Manufacturing Base and Competitors
Table 68. Genethon SA Major Business
Table 69. Genethon SA Sickle Cell Disease Drug Product and Services
Table 70. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Gilead Sciences Inc Basic Information, Manufacturing Base and Competitors
Table 72. Gilead Sciences Inc Major Business
Table 73. Gilead Sciences Inc Sickle Cell Disease Drug Product and Services
Table 74. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Blood Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 76. Global Blood Therapeutics Inc Major Business
Table 77. Global Blood Therapeutics Inc Sickle Cell Disease Drug Product and Services
Table 78. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Global Sickle Cell Disease Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 80. Global Sickle Cell Disease Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 81. Market Position of Manufacturers in Sickle Cell Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 82. Global Sickle Cell Disease Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 83. Head Office and Sickle Cell Disease Drug Production Site of Key Manufacturer
Table 84. Sickle Cell Disease Drug New Entrant and Capacity Expansion Plans
Table 85. Sickle Cell Disease Drug Mergers & Acquisitions in the Past Five Years
Table 86. Global Sickle Cell Disease Drug Sales by Region (2016-2021e) & (K Pcs)
Table 87. Global Sickle Cell Disease Drug Sales by Region (2021-2026) & (K Pcs)
Table 88. Global Sickle Cell Disease Drug Revenue by Region (2016-2021e) & (USD Million)
Table 89. Global Sickle Cell Disease Drug Revenue by Region (2021-2026) & (USD Million)
Table 90. Global Sickle Cell Disease Drug Sales by Type (2016-2021e) & (K Pcs)
Table 91. Global Sickle Cell Disease Drug Sales by Type (2021-2026) & (K Pcs)
Table 92. Global Sickle Cell Disease Drug Revenue by Type (2016-2021e) & (USD Million)
Table 93. Global Sickle Cell Disease Drug Revenue by Type (2021-2026) & (USD Million)
Table 94. Global Sickle Cell Disease Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 95. Global Sickle Cell Disease Drug Price by Type (2021-2026) & (USD/Pcs)
Table 96. Global Sickle Cell Disease Drug Sales by Application (2016-2021e) & (K Pcs)
Table 97. Global Sickle Cell Disease Drug Sales by Application (2021-2026) & (K Pcs)
Table 98. Global Sickle Cell Disease Drug Revenue by Application (2016-2021e) & (USD Million)
Table 99. Global Sickle Cell Disease Drug Revenue by Application (2021-2026) & (USD Million)
Table 100. Global Sickle Cell Disease Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 101. Global Sickle Cell Disease Drug Price by Application (2021-2026) & (USD/Pcs)
Table 102. North America Sickle Cell Disease Drug Sales by Country (2016-2021e) & (K Pcs)
Table 103. North America Sickle Cell Disease Drug Sales by Country (2021-2026) & (K Pcs)
Table 104. North America Sickle Cell Disease Drug Revenue by Country (2016-2021e) & (USD Million)
Table 105. North America Sickle Cell Disease Drug Revenue by Country (2021-2026) & (USD Million)
Table 106. North America Sickle Cell Disease Drug Sales by Type (2016-2021e) & (K Pcs)
Table 107. North America Sickle Cell Disease Drug Sales by Type (2021-2026) & (K Pcs)
Table 108. North America Sickle Cell Disease Drug Sales by Application (2016-2021e) & (K Pcs)
Table 109. North America Sickle Cell Disease Drug Sales by Application (2021-2026) & (K Pcs)
Table 110. Europe Sickle Cell Disease Drug Sales by Country (2016-2021e) & (K Pcs)
Table 111. Europe Sickle Cell Disease Drug Sales by Country (2021-2026) & (K Pcs)
Table 112. Europe Sickle Cell Disease Drug Revenue by Country (2016-2021e) & (USD Million)
Table 113. Europe Sickle Cell Disease Drug Revenue by Country (2021-2026) & (USD Million)
Table 114. Europe Sickle Cell Disease Drug Sales by Type (2016-2021e) & (K Pcs)
Table 115. Europe Sickle Cell Disease Drug Sales by Type (2021-2026) & (K Pcs)
Table 116. Europe Sickle Cell Disease Drug Sales by Application (2016-2021e) & (K Pcs)
Table 117. Europe Sickle Cell Disease Drug Sales by Application (2021-2026) & (K Pcs)
Table 118. Asia-Pacific Sickle Cell Disease Drug Sales by Region (2016-2021e) & (K Pcs)
Table 119. Asia-Pacific Sickle Cell Disease Drug Sales by Region (2021-2026) & (K Pcs)
Table 120. Asia-Pacific Sickle Cell Disease Drug Revenue by Region (2016-2021e) & (USD Million)
Table 121. Asia-Pacific Sickle Cell Disease Drug Revenue by Region (2021-2026) & (USD Million)
Table 122. Asia-Pacific Sickle Cell Disease Drug Sales by Type (2016-2021e) & (K Pcs)
Table 123. Asia-Pacific Sickle Cell Disease Drug Sales by Type (2021-2026) & (K Pcs)
Table 124. Asia-Pacific Sickle Cell Disease Drug Sales by Application (2016-2021e) & (K Pcs)
Table 125. Asia-Pacific Sickle Cell Disease Drug Sales by Application (2021-2026) & (K Pcs)
Table 126. South America Sickle Cell Disease Drug Sales by Country (2016-2021e) & (K Pcs)
Table 127. South America Sickle Cell Disease Drug Sales by Country (2021-2026) & (K Pcs)
Table 128. South America Sickle Cell Disease Drug Revenue by Country (2016-2021e) & (USD Million)
Table 129. South America Sickle Cell Disease Drug Revenue by Country (2021-2026) & (USD Million)
Table 130. South America Sickle Cell Disease Drug Sales by Type (2016-2021e) & (K Pcs)
Table 131. South America Sickle Cell Disease Drug Sales by Type (2021-2026) & (K Pcs)
Table 132. South America Sickle Cell Disease Drug Sales by Application (2016-2021e) & (K Pcs)
Table 133. South America Sickle Cell Disease Drug Sales by Application (2021-2026) & (K Pcs)
Table 134. Middle East & Africa Sickle Cell Disease Drug Sales by Country (2016-2021e) & (K Pcs)
Table 135. Middle East & Africa Sickle Cell Disease Drug Sales by Country (2021-2026) & (K Pcs)
Table 136. Middle East & Africa Sickle Cell Disease Drug Revenue by Country (2016-2021e) & (USD Million)
Table 137. Middle East & Africa Sickle Cell Disease Drug Revenue by Country (2021-2026) & (USD Million)
Table 138. Middle East & Africa Sickle Cell Disease Drug Sales by Type (2016-2021e) & (K Pcs)
Table 139. Middle East & Africa Sickle Cell Disease Drug Sales by Type (2021-2026) & (K Pcs)
Table 140. Middle East & Africa Sickle Cell Disease Drug Sales by Application (2016-2021e) & (K Pcs)
Table 141. Middle East & Africa Sickle Cell Disease Drug Sales by Application (2021-2026) & (K Pcs)
Table 142. Direct Channel Pros & Cons
Table 143. Indirect Channel Pros & Cons
Table 144. Sickle Cell Disease Drug Typical Distributors
Table 145. Sickle Cell Disease Drug Typical Customers
List of Figures
Figure 1. Sickle Cell Disease Drug Picture
Figure 2. Global Sickle Cell Disease Drug Sales Market Share by Type in 2020
Figure 3. ARQ-092
Figure 4. BIVV-003
Figure 5. CAL-H
Figure 6. CTX-001
Figure 7. DRX-194
Figure 8. Others
Figure 9. Global Sickle Cell Disease Drug Sales Market Share by Application in 2020
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Sickle Cell Disease Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Sickle Cell Disease Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Sickle Cell Disease Drug Sales (2016-2026) & (K Pcs)
Figure 16. Global Sickle Cell Disease Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 17. Global Sickle Cell Disease Drug Production Capacity (2016-2026) & (K Pcs)
Figure 18. Global Sickle Cell Disease Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Sickle Cell Disease Drug Market Drivers
Figure 20. Sickle Cell Disease Drug Market Restraints
Figure 21. Sickle Cell Disease Drug Market Trends
Figure 22. Global Sickle Cell Disease Drug Sales Market Share by Manufacturer in 2020
Figure 23. Global Sickle Cell Disease Drug Revenue Market Share by Manufacturer in 2020
Figure 24. Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Sickle Cell Disease Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Sickle Cell Disease Drug Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Sickle Cell Disease Drug Sales Market Share by Region (2016-2026)
Figure 28. Global Sickle Cell Disease Drug Revenue Market Share by Region (2016-2026)
Figure 29. North America Sickle Cell Disease Drug Revenue (2016-2026) & (USD Million)
Figure 30. Europe Sickle Cell Disease Drug Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Sickle Cell Disease Drug Revenue (2016-2026) & (USD Million)
Figure 32. South America Sickle Cell Disease Drug Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Sickle Cell Disease Drug Revenue (2016-2026) & (USD Million)
Figure 34. Global Sickle Cell Disease Drug Sales Market Share by Type (2016-2026)
Figure 35. Global Sickle Cell Disease Drug Revenue Market Share by Type (2016-2026)
Figure 36. Global Sickle Cell Disease Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 37. Global Sickle Cell Disease Drug Sales Market Share by Application (2016-2026)
Figure 38. Global Sickle Cell Disease Drug Revenue Market Share by Application (2016-2026)
Figure 39. Global Sickle Cell Disease Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 40. North America Sickle Cell Disease Drug Sales Market Share by Type (2016-2026)
Figure 41. North America Sickle Cell Disease Drug Sales Market Share by Application (2016-2026)
Figure 42. North America Sickle Cell Disease Drug Sales Market Share by Country (2016-2026)
Figure 43. North America Sickle Cell Disease Drug Revenue Market Share by Country (2016-2026)
Figure 44. United States Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Sickle Cell Disease Drug Sales Market Share by Type (2016-2026)
Figure 48. Europe Sickle Cell Disease Drug Sales Market Share by Application (2016-2026)
Figure 49. Europe Sickle Cell Disease Drug Sales Market Share by Country (2016-2026)
Figure 50. Europe Sickle Cell Disease Drug Revenue Market Share by Country (2016-2026)
Figure 51. Germany Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Sickle Cell Disease Drug Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Sickle Cell Disease Drug Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Sickle Cell Disease Drug Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Sickle Cell Disease Drug Revenue Market Share by Region (2016-2026)
Figure 60. China Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Sickle Cell Disease Drug Sales Market Share by Type (2016-2026)
Figure 67. South America Sickle Cell Disease Drug Sales Market Share by Application (2016-2026)
Figure 68. South America Sickle Cell Disease Drug Sales Market Share by Country (2016-2026)
Figure 69. South America Sickle Cell Disease Drug Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Sickle Cell Disease Drug Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Sickle Cell Disease Drug Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Sickle Cell Disease Drug Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Sickle Cell Disease Drug Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Sickle Cell Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のシャルコー・マリー・トゥース病I型A型治療薬市場 2021：企業別、地域別、種類・用途別 The Charcot-Marie-Tooth Disease Type I A Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 世界のシャーガス病治療薬市場 2021：企業別、地域別、種類・用途別 The Chagas Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の末梢動脈疾患用薬剤溶出性バルーン市場 2021：企業別、地域別、種類・用途別 The Drug Eluting Balloon for Peripheral Artery Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- 世界の鎌式草刈り機市場 2021：企業別、地域別、種類・用途別 The Sickle Mower market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…
- 世界のびまん性大細胞型B細胞リンパ腫薬市場 2021：企業別、地域別、種類・用途別 The Diffuse Large B Cell Lymphoma Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…